Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
13.29
+0.25 (1.92%)
At close: Jul 1, 2026, 4:00 PM EDT
13.55
+0.26 (1.96%)
After-hours: Jul 1, 2026, 6:46 PM EDT
Climb Bio Employees
As of December 31, 2025, Climb Bio had 29 total employees, including 28 full-time and 1 part-time employees. The number of employees increased by 11 or 61.11% compared to the previous year.
Employees
29
Change (1Y)
11
Growth (1Y)
61.11%
Revenue / Employee
n/a
Profits / Employee
-$1,820,414
Market Cap
760.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 11 | 61.11% | 28 | 1 |
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| Rigel Pharmaceuticals | 174 |
| Allogene Therapeutics | 152 |
| Aura Biosciences | 113 |
| Aclaris Therapeutics | 73 |
| SpyGlass Pharma | 68 |
| Candel Therapeutics | 55 |
| Immix Biopharma | 21 |
| Relmada Therapeutics | 17 |
CLYM News
- 20 days ago - Climb Bio price target raised to $20 from $19 at BTIG - TheFly
- 20 days ago - Climb Bio announces initial data from budoprutug study at EHA - TheFly
- 20 days ago - Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026 - GlobeNewsWire
- 23 days ago - Climb Bio initiated with a Buy at Guggenheim - TheFly
- 26 days ago - Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development - GlobeNewsWire
- 27 days ago - Climb Bio Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Climb Bio registers to sell 11.59M shares of common stock for holders - TheFly
- 4 weeks ago - Climb Bio Registration statement: Registration filing - Filings